
Summer 2017
The clumpy, bulbous appearance of this organoid from the Spector lab reflects the aggressive nature of the breast cancer subtype it was grown from. After 6 days of treatment with antisense technology that knocks down a long non-coding RNA called MaTAR20, the cancer shrank and lost its branched appearance, suggesting loss of metastatic potential.